Changes for page Neurodiagnoses

Last modified by manuelmenendez on 2025/03/03 22:46
From version 25.1
edited by manuelmenendez
on 2025/01/29 18:47
Change comment: There is no comment for this version
To version 23.1
edited by manuelmenendez
on 2025/01/29 18:46
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -23,7 +23,9 @@
23 23  * **Axis 2**: Molecular Markers (biomarkers).
24 24  * **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system).
25 25  
26 +[[For instance, neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
26 26  
28 +
27 27  This methodology enables:
28 28  
29 29  * Greater precision in diagnosis.
... ... @@ -34,8 +34,6 @@
34 34  
35 35  There have been described these 3 diagnostic axes:
36 36  
37 -[[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
38 -
39 39  * (((
40 40  **Axis 1: Etiology**
41 41